Insider Transactions in Q4 2025 at Taysha Gene Therapies, Inc. (TSHA)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2025
|
Sukumar Nagendran President and Head of R&D |
SELL
Open market or private sale
|
Direct |
260,047
-20.53%
|
$1,040,188
$4.51 P/Share
|
|
Dec 01
2025
|
Sukumar Nagendran President and Head of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
260,047
+17.04%
|
$260,047
$1.71 P/Share
|
|
Nov 28
2025
|
Sukumar Nagendran President and Head of R&D |
SELL
Open market or private sale
|
Direct |
110,125
-9.86%
|
$440,500
$4.75 P/Share
|
|
Nov 28
2025
|
Sukumar Nagendran President and Head of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
110,125
+4.79%
|
$110,125
$1.21 P/Share
|